Suppr超能文献

H1受体拮抗剂生物学与药理学的里程碑

Milestones in the biology and pharmacology of H1-receptor antagonists.

作者信息

Marone G

机构信息

Department of Medicine, School of Medicine, University of Naples Federico II, Italy.

出版信息

Allergy. 1997;52(34 Suppl):7-13. doi: 10.1111/j.1398-9995.1997.tb04806.x.

Abstract

Daniele Bovet's pioneering discovery that a series of compounds possessing anti-histamine activity reduced the symptoms of anaphylaxis provided the proof that histamine plays a pivotal role as a mediator of allergic reactions. Basophils and mast cells are the major sources of histamine in man and they are thus one of the primary effector cells of allergic inflammation. Some H1-receptor antagonists possess a variety of antiinflammatory activity to H1 antagonism in vitro and in vivo. This promising area should be explored further and much remains to be done in the evaluation of the immunomodulatory effects of anti-histamines.

摘要

丹尼尔·博韦的开创性发现,即一系列具有抗组胺活性的化合物可减轻过敏反应症状,证明了组胺作为过敏反应介质起着关键作用。嗜碱性粒细胞和肥大细胞是人体组胺的主要来源,因此它们是过敏性炎症的主要效应细胞之一。一些H1受体拮抗剂在体外和体内对H1拮抗作用具有多种抗炎活性。这个有前景的领域应进一步探索,在评估抗组胺药的免疫调节作用方面仍有许多工作要做。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验